Regenerative Research Fdn/NSCI

14 Followers
14 Following
268 Posts
RRF/Neural Stem Cell Institute is the first independent, non-profit stem cell research institute in the U.S. NSCI is dedicated to developing therapies for conditions of the nervous system, including #neurodegeneration, #spinalcordinjury and #maculardegeneration. Twitter @NeuralStemCells
Luxa Biotechnology LLC posted on LinkedIn

Luxa Biotechnology LLC posted images on LinkedIn

Have a safe and happy Halloween!

Stem cell research is opening new doors for treating age-related #MacularDegeneration (AMD), a leading cause of vision loss.

Join our co-founders, Drs. Jeffrey Stern and Sally Temple on @BrightFocus Foundation's Macular Chat on Wed, Oct 29. They'll break down the science, share clinical trial updates, and explain what these advances mean for people living with AMD.

Register today and ask your questions live: https://zurl.co/5PL54

A great piece by our friends at Michigan Medicine! We are grateful to have our first clinical trial in the skilled hands of Drs. Rajesh Rao of Kellogg Eye Center, David Liao of LA Retina and Theodore Leng of Stanford Medicine.

Article | https://zurl.co/0eUMo

Adult stem cells show therapeutic promise in treating vision loss from macular degeneration

Researchers used retinal pigment epithelial stem cells derived from adult postmortem eye tissue in a phase 1/2a clinical trial. This is the first treatment to show promise for age-related macular degeneration or AMD.

Science fun on this beautiful Friday in Albany! The Capital District Postdoc Association held their annual symposium at the University at Albany. NSCI was well represented by CDPA president Sol Toruella, presenters Runia Roy & Catherine Hamann, and new postdocs Jenica Acheta & Alexis Guevara!

Our #NEIfunded study led by Farhad Farjood, Nathan Boles & Jeffrey Stern reveals heterogeneity of retinal pigment epithelium cells in the human eye using #scRNA-seq & proteomics. We describe unique spatial patterns that suggest functional differences for RPE subpopulations in the eye.

- with S. Nandakumar, T. Bertucci, T. Kiehl, S. Lotz, Yue Wang, J. Black, S. Sai, J. Kozak, B. Arduini and S. Temple

This work was supported by the NIH & Luxa Biotech.

Full text | https://zurl.co/4hwI6

🔊 Are you a detail-oriented PhD scientist with cell biology or #biomanufacturing experience? Interested in development of a novel clinical stage cell replacement therapy for dry age-related #MacularDegeneration (AMD)? We are #hiring!

Learn more: https://zurl.co/uwrDd

Today, Liz Fisher presents "PLD3 contributions to vascular dysfunction in the context of AD" during the poster session at #AAIC2025!

Poster | #107171
Time | 7:30AM – 4:15PM
Where | Exhibit Hall

Today at #AAIC2025: Taylor Bertucci presents "APOE4 alters vascular cells in cognitively normal brains and in vitro models revealing early pathogenic AD contributions of endothelial cells."

Session | Dissecting molecular disease mechanisms
Time | 2:00 – 3:30PM
Location | Hall G

Coming up at #AAIC2025, Taylor Bertucci and Liz Fisher will present data related to APOE and PLD3 contributions to vascular dysfunction in #Alzheimers Disease. Check it out!

Alzheimer's Association | https://zurl.co/jgQ7m

AAIC | July 27-31, 2025 | Alzheimer's Association

The Alzheimer's Association International Conference is the world's largest forum for the dementia research community. Toronto, Canada, and online.

AAIC | July 27-31, 2025 | Alzheimer's Association